OZEM — Roundhill GLP-1 & Weight Loss ETF
—
NGM ·
Health Care ·
Developed Markets ·
CIK ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $25.00 · spot: $29.93 · call volume: 29 · put volume: 202News headlines (Yahoo Finance, 1h cache)
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win
2026-10-01 12:48 · Yahoo
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
2026-06-20 12:45 · Yahoo
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
2026-06-10 16:00 · Yahoo
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
2026-05-19 18:27 · Yahoo
Scoring 2 Million Prescriptions, Novo’s GLP-1 Pill Crushes Expectations
2026-05-07 04:01 · Yahoo
3 Ways to Invest in the Growing GLP-1 Weight Loss Market
2026-04-17 15:20 · Yahoo
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
2026-07-01 12:13 · Yahoo
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All
2026-01-19 20:23 · Yahoo
2 under-the-radar ETFs retail investors should jump on
2026-01-07 11:00 · Yahoo
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug
2025-12-29 13:46 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.